You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 91 No. 6, JUNE 1953 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

TREATMENT OF CENTRAL NERVOUS SYSTEM CRYPTOCOCCOSIS

Laboratory Studies

CHARLES A. CARTON, M.D.; CHARLOTTE S. LIEBIG, B.A.

AMA Arch Intern Med. 1953;91(6):773-783.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

THE PROBLEM of therapy in infections with Cryptococcus neoformans remains unsolved. In a previous publication1 the use of a wide variety of drugs in the treatment of central nervous system cryptococcosis was reviewed, with particular emphasis on the results obtained with fever therapy, protoanemonin, Bacillus subtilis derivatives and cycloheximide (Acti-Dione). Experience with the latter drug was summarized and its use in four cases of central nervous system cryptococcosis reported with improvement in one case (the patient subsequently dying) and perhaps a cure in another; the latter patient has been followed for one and one-half years without relapse of the disease. Wilson and Duryea2 have likewise reported a "cure" with cycloheximide. However, in other cases of cryptococcic meningitis cycloheximide appeared to have had no effect upon the course of the infection. Other agents have since been reported as having an inhibitory or fungicidal effect against C. neoformans; namely, prodigiosin, . . . [Full Text PDF of this Article]


Author Affiliations

NEW YORK

From the Departments of Neurosurgery and Microbiology, College of Physicians and Surgeons, Columbia University.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1953 American Medical Association. All Rights Reserved.